{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:21:02Z","timestamp":1771489262832,"version":"3.50.1"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Sci Pollut Res"],"DOI":"10.1007\/s11356-022-24032-2","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T15:02:30Z","timestamp":1669906950000},"page":"9164-9183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19"],"prefix":"10.1007","volume":"30","author":[{"given":"Neelam","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahid Nazir","family":"Wani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhbir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishrat","family":"Zahoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aayush","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotfi","family":"Aleya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"24032_CR1","doi-asserted-by":"publisher","unstructured":"Agnihotri AK, Vij M, Aruoma OI, Yagnik VD, Bahorun T, Villamil ME, Menezes GA, Gupta V (2021) The double trouble: COVID-19 associated mucormycosis a focused review and future perspectives. Glob J Med Pharm Biomed Update 16: 1\u20136. https:\/\/doi.org\/10.25259\/GJMPBU_4_2021","DOI":"10.25259\/GJMPBU_4_2021"},{"key":"24032_CR2","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1128\/AAC.01467-08","volume":"53","author":"A Alastruey-Izquierdo","year":"2009","unstructured":"Alastruey-Izquierdo A, Castelli MV, Cuesta I, Monzon A, Cuenca-Estrella M, Rodriguez-Tudela JL (2009) Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers. Antimicrob Agents Chemother 53:1686\u20131689. https:\/\/doi.org\/10.1128\/AAC.01467-08","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.14740\/jmc3637","volume":"12","author":"K Alekseyev","year":"2021","unstructured":"Alekseyev K, Didenko L, Chaudhry B (2021) Rhino cerebral mucormycosis and COVID-19 pneumonia. J Med Cases 12:85. https:\/\/doi.org\/10.14740\/jmc3637","journal-title":"J Med Cases"},{"key":"24032_CR4","doi-asserted-by":"publisher","first-page":"e01087","DOI":"10.1128\/mBio.01087-20","volume":"11","author":"A Alqarihi","year":"2020","unstructured":"Alqarihi A, Gebremariam T, Gu Y, Swidergall M, Alkhazraji S, Soliman SS, Bruno VM, Edwards JE Jr, Filler SG, Uppuluri P, Ibrahim AS (2020) GRP78 and integrins play different roles in host cell invasion during mucormycosis. mBio 11:e01087\u2013e01120. https:\/\/doi.org\/10.1128\/mBio.01087-20","journal-title":"mBio"},{"key":"24032_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijid.2009.11.024","volume":"14","author":"J Ambrosioni","year":"2010","unstructured":"Ambrosioni J, Bouchuiguir-Wafa K, Garbino J (2010) Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. Int J Infect Dis 14:100\u2013103. https:\/\/doi.org\/10.1016\/j.ijid.2009.11.024","journal-title":"Int J Infect Dis"},{"key":"24032_CR6","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3390\/idr13040093","volume":"13","author":"A Amin","year":"2021","unstructured":"Amin A, Vartanian A, Poladian N, Voloshko A, Yegiazaryan A, Al-Kassir AL, Venketaraman V (2021) Root causes of fungal coinfections in COVID-19 infected patients. Infect Dis Rep 13:1018\u20131035. https:\/\/doi.org\/10.3390\/idr13040093","journal-title":"Infect Dis Rep"},{"key":"24032_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1309\/AJCPRAAE8LZ7DTNE","volume":"132","author":"S Antinori","year":"2009","unstructured":"Antinori S, Nebuloni M, Magni C, Fasan M, Adorni F, Viola A, Corbellino M, Galli M, Vago G, Parravicini C, Ridolfo AL (2009) Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. Am J Clin Pathol 132:221\u2013227. https:\/\/doi.org\/10.1309\/AJCPRAAE8LZ7DTNE","journal-title":"Am J Clin Pathol"},{"key":"24032_CR8","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1086\/319985","volume":"32","author":"JW Baddley","year":"2001","unstructured":"Baddley JW, Stroud TP, Salzman D, Pappas PG (2001) Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 32:1319\u20131324. https:\/\/doi.org\/10.1086\/319985","journal-title":"Clin Infect Dis"},{"key":"24032_CR9","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/infdis\/jiw513","volume":"215","author":"SR Baistrocchi","year":"2017","unstructured":"Baistrocchi SR, Lee MJ, Lehoux M, Ralph B, Snarr BD, Robitaille R, Sheppard DC (2017) Posaconazole-loaded leukocytes as a novel treatment strategy targeting invasive pulmonary aspergillosis. J Infect Dis 215:1734\u20131741. https:\/\/doi.org\/10.1093\/infdis\/jiw513","journal-title":"J Infect Dis"},{"key":"24032_CR10","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1128\/AAC.00956-09","volume":"54","author":"R Ben-Ami","year":"2010","unstructured":"Ben-Ami R, Lewis RE, Tarrand J, Leventakos K, Kontoyiannis DP (2010) Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection. Antimicrob Agents Chemother 54:484\u2013490. https:\/\/doi.org\/10.1128\/AAC.00956-09","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jinf.2009.06.002","volume":"59","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R, Luna M, Lewis RE, Walsh TJ, Kontoyiannis DP (2009) A clini-copathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response. J Infect 59:134\u2013138. https:\/\/doi.org\/10.1016\/j.jinf.2009.06.002","journal-title":"J Infect"},{"key":"24032_CR12","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1093\/jac\/dkaa326","volume":"75","author":"B Beovi\u0107","year":"2020","unstructured":"Beovi\u0107 B, Dou\u0161ak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M, Berger-Estilita J, Ayoade F, Rello J, Erdem H (2020) Antibiotic use in patients with COVID-19: a \u2018snapshot\u2019 Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother 75:3386\u20133390. https:\/\/doi.org\/10.1093\/jac\/dkaa326","journal-title":"J Antimicrob Chemother"},{"key":"24032_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/ckj\/sfy034","volume":"11","author":"D Bhadauria","year":"2018","unstructured":"Bhadauria D, Etta P, Chelappan A, Gurjar M, Kaul A, Sharma RK, Gupta A, Prasad N, Marak RS, Jain M, Srivastava A (2018) Isolated bilateral renal mucormycosis in apparently immunocompetent patients-a case series from India and review of the literature. Clin Kidney J 11:769\u2013776. https:\/\/doi.org\/10.1093\/ckj\/sfy034","journal-title":"Clin Kidney J"},{"key":"24032_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/pgmj.2003.016030","volume":"80","author":"A Bhansali","year":"2004","unstructured":"Bhansali A, Bhadada S, Sharma A, Suresh V, Gupta A, Singh P, Chakarbarti A, Dash RJ (2004) Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 80:670\u2013674. https:\/\/doi.org\/10.1136\/pgmj.2003.016030","journal-title":"Postgrad Med J"},{"key":"24032_CR15","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.1128\/AAC.01698-15","volume":"59","author":"T Bicanic","year":"2015","unstructured":"Bicanic T, Bottomley C, Loyse A, Brouwer AE, Muzoora C, Taseera K, Jackson A, Phulusa J, Hosseinipour MC, Van Der Horst C, Limmathurotsakul D (2015) Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis. Antimicrob Agents Chemother 59:7224\u20137231. https:\/\/doi.org\/10.1128\/AAC.01698-15","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/1469-0691.12566","volume":"20","author":"U Binder","year":"2014","unstructured":"Binder U, Maurer E, Lass-Fl\u00f6rl C (2014) Mucormycosis-from the pathogens to the disease. Clin Microbiol Infect 20:60\u201366. https:\/\/doi.org\/10.1111\/1469-0691.12566","journal-title":"Clin Microbiol Infect"},{"key":"24032_CR17","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3201\/eid1509.090334","volume":"15","author":"D Bitar","year":"2009","unstructured":"Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos JC, Lortholary O (2009) Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006. Emerg Infect Dis 15:1395. https:\/\/doi.org\/10.3201\/eid1509.090334","journal-title":"Emerg Infect Dis"},{"key":"24032_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.101007","volume":"30","author":"K Brunet","year":"2020","unstructured":"Brunet K, Rammaert B (2020) Mucormycosis treatment: recommendations, latest advances, and perspectives. J Mycol Med 30:101007. https:\/\/doi.org\/10.1016\/j.mycmed.2020.101007","journal-title":"J Mycol Med"},{"key":"24032_CR19","unstructured":"Bruno, Watkins V, Tonya N, Ibrahim A (2020) Methods of treating or preventing mucormycosis. WO2020006438"},{"key":"24032_CR21","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.3389\/fphar.2020.598308","volume":"11","author":"G Cavalli","year":"2020","unstructured":"Cavalli G, Farina N, Campochiaro C, De Luca G, Della-Torre E, Tomelleri A, Dagna L (2020) Repurposing of biologic and targeted synthetic anti-rheumatic drugs in COVID-19and hyper-inflammation: a comprehensive review of available and emerging evidence at the peak of the pandemic. Front Pharmacol 11:2111. https:\/\/doi.org\/10.3389\/fphar.2020.598308","journal-title":"Front Pharmacol"},{"key":"24032_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","volume":"85","author":"A Chakrabarti","year":"2009","unstructured":"Chakrabarti A, Chatterjee SS, Das A, Panda N, Shivaprakash MR, Kaur A, Varma SC, Singhi S, Bhansali A, Sakhuja V (2009) Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J 85:573\u2013581. https:\/\/doi.org\/10.1136\/pgmj.2008.076463","journal-title":"Postgrad Med J"},{"key":"24032_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/13693780500464930","volume":"44","author":"A Chakrabarti","year":"2006","unstructured":"Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, Rao P, Panda N, Verma SC, Sakhuja V (2006) The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Sabouraudia 44:335\u2013342. https:\/\/doi.org\/10.1080\/13693780500464930","journal-title":"Sabouraudia"},{"key":"24032_CR24","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1128\/JCM.01272-09","volume":"48","author":"A Chakrabarti","year":"2010","unstructured":"Chakrabarti A, Marak RS, Shivaprakash MR, Gupta S, Garg R, Sakhuja V, Singhal S, Baghela A, Dixit A, Garg MK, Padhye AA (2010) Cavitary pulmonary zygomycosis caused by Rhizopus homothallicus. J Clin Microbiol 48:1965\u20131969. https:\/\/doi.org\/10.1128\/JCM.01272-09","journal-title":"J Clin Microbiol"},{"key":"24032_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/myc.12243","volume":"57","author":"A Chakrabarti","year":"2014","unstructured":"Chakrabarti A, Singh R (2014) Mucormycosis in India: unique features. Mycoses 57:85\u201390. https:\/\/doi.org\/10.1111\/myc.12243","journal-title":"Mycoses"},{"key":"24032_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12281-019-0337-1","volume":"13","author":"S Challa","year":"2019","unstructured":"Challa S (2019) Mucormycosis: pathogenesis and pathology. Curr Fungal Infect Rep 13:11\u201320. https:\/\/doi.org\/10.1007\/s12281-019-0337-1","journal-title":"Curr Fungal Infect Rep"},{"key":"24032_CR27","doi-asserted-by":"publisher","first-page":"9367","DOI":"10.1073\/pnas.0709578105","volume":"105","author":"G Chamilos","year":"2008","unstructured":"Chamilos G, Lewis RE, Hu J, Xiao L, Zal T, Gilliet M, Halder G, Kontoyiannis DP (2008a) Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci 105:9367\u20139372. https:\/\/doi.org\/10.1073\/pnas.0709578105","journal-title":"Proc Natl Acad Sci"},{"key":"24032_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1128\/AAC.50.1.96-103.2006","volume":"50","author":"G Chamilos","year":"2006","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP (2006a) Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother 50:96\u2013103. https:\/\/doi.org\/10.1128\/AAC.50.1.96-103.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/590004","volume":"47","author":"G Chamilos","year":"2008","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP (2008b) Delaying amphotericin B\u2013based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 47:503\u2013509. https:\/\/doi.org\/10.1086\/590004","journal-title":"Clin Infect Dis"},{"key":"24032_CR30","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3324\/%25x","volume":"91","author":"G Chamilos","year":"2006","unstructured":"Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Kontoyiannis DP (2006b) Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989\u20132003). Haematologica 91:986\u2013989. https:\/\/doi.org\/10.3324\/%25x","journal-title":"Haematologica"},{"key":"24032_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/23744235.2016.1239027","volume":"49","author":"J Chander","year":"2017","unstructured":"Chander J, Singla N, Kaur M, Punia RS, Attri A, Alastruey-Izquierdo A, Cano-Lira JF, Stchigel AM, Guarro J (2017) Saksenaea erythrospora, an emerging mucoralean fungus causing severe necrotizing skin and soft tissue infections\u2013a study from a tertiary care hospital in north India. Infect Dis 49:170\u2013177. https:\/\/doi.org\/10.1080\/23744235.2016.1239027","journal-title":"Infect Dis"},{"key":"24032_CR32","unstructured":"Chaojie H, Meng Z, Huaxiang H, Tao Z (2022) Kit and method for detecting mucormycosis pathogens. CN11457460"},{"key":"24032_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10096-006-0107-1","volume":"25","author":"M Chayakulkeeree","year":"2006","unstructured":"Chayakulkeeree M, Ghannoum MA, Perfect JR (2006) Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 25:215\u2013229. https:\/\/doi.org\/10.1007\/s10096-006-0107-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"24032_CR34","doi-asserted-by":"publisher","first-page":"e01941","DOI":"10.1128\/AAC.01941-17","volume":"62","author":"T Colley","year":"2018","unstructured":"Colley T, Sehra G, Chowdhary A, Alanio A, Kelly SL, Kizawa Y, Armstrong-James D, Fisher MC, Warrilow AG, Parker JE, Kelly DE (2018) In vitro and in vivo efficacy of a novel and long-acting fungicidal azole, PC1244, on Aspergillus fumigatus infection. Antimicrob Agents Chemother 62:e01941\u2013e02017. https:\/\/doi.org\/10.1128\/AAC.01941-17","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"OA Cornely","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SC, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC (2019) Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 19:405\u2013421. https:\/\/doi.org\/10.1016\/S1473-3099(19)30312-3","journal-title":"Lancet Infect Dis"},{"key":"24032_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.medcle.2020.11.015","volume":"156","author":"F Deng","year":"2021","unstructured":"Deng F, Zhang L, Lyu L, Lu Z, Gao D, Ma X, Guo Y, Wang R, Gong S, Jiang W (2021) Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19. Med Clin 156:324\u2013331. https:\/\/doi.org\/10.1016\/j.medcle.2020.11.015","journal-title":"Med Clin"},{"key":"24032_CR37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1258\/002221503322542854","volume":"117","author":"M Dhiwakar","year":"2003","unstructured":"Dhiwakar M, Thakar A, Bahadur S (2003) Improving outcomes in rhinocerebral mucormycosis-early diagnostic pointers and prognostic factors. J Laryngol Otol 117:861\u2013865. https:\/\/doi.org\/10.1258\/002221503322542854","journal-title":"J Laryngol Otol"},{"key":"24032_CR38","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G, Yuan Z (2020) Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 11:827. https:\/\/doi.org\/10.3389\/fimmu.2020.00827","journal-title":"Front Immunol"},{"key":"24032_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.12703\/P6-81","volume":"6","author":"MC Dignani","year":"2014","unstructured":"Dignani MC (2014) Epidemiology of invasive fungal diseases on the basis of autopsy reports. F1000Prime Rep 6:81. https:\/\/doi.org\/10.12703\/P6-81","journal-title":"F1000Prime Rep"},{"key":"24032_CR40","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/myc.12419","volume":"58","author":"MV Dioverti","year":"2015","unstructured":"Dioverti MV, Cawcutt KA, Abidi M, Sohail MR, Walker RC, Osmon DR (2015) Gastrointestinal mucormycosis in immunocompromised hosts. Mycoses 58:714\u2013718. https:\/\/doi.org\/10.1111\/myc.12419","journal-title":"Mycoses"},{"key":"24032_CR41","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC (2020) Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 71:1367\u20131367. https:\/\/doi.org\/10.1093\/cid\/ciz1008","journal-title":"Clin Infect Dis"},{"key":"24032_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijid.2020.05.110","volume":"97","author":"M Edeas","year":"2020","unstructured":"Edeas M, Saleh J, Peyssonnaux C (2020) Iron: innocent bystander or vicious culprit in COVID-19 pathogenesis? Int J Infect Dis 97:303\u2013305. https:\/\/doi.org\/10.1016\/j.ijid.2020.05.110","journal-title":"Int J Infect Dis"},{"key":"24032_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/IDR.S51340","volume":"6","author":"DR Falci","year":"2013","unstructured":"Falci DR, Pasqualotto AC (2013) Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections. Infect Drug Resist 6:163. https:\/\/doi.org\/10.2147\/IDR.S51340","journal-title":"Infect Drug Resist"},{"key":"24032_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s15010-018-1149-x","volume":"46","author":"J Feng","year":"2018","unstructured":"Feng J, Sun X (2018) Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome. Infection 46:503\u2013512. https:\/\/doi.org\/10.1007\/s15010-018-1149-x","journal-title":"Infection"},{"key":"24032_CR45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/bmt.2016.306","volume":"52","author":"S Fuji","year":"2017","unstructured":"Fuji S, Loffler J, Savani B, Einsele H, Kapp M (2017) Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in 123 Mycopathologia allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 52:657\u2013662. https:\/\/doi.org\/10.1038\/bmt.2016.306","journal-title":"Bone Marrow Transplant"},{"key":"24032_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.100971","volume":"30","author":"JP Gangneux","year":"2020","unstructured":"Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR (2020) Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med 30:100971. https:\/\/doi.org\/10.1016\/j.mycmed.2020.100971","journal-title":"J Mycol Med"},{"key":"24032_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","volume":"186","author":"D Garg","year":"2021","unstructured":"Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, Puri GD, Chakrabarti A, Agarwal R (2021) Coronavirus disease (Covid-19) associated mucormycosis(cam): case report and systematic review of literature. Mycopathologia 186:289\u2013298. https:\/\/doi.org\/10.1007\/s11046-021-00528-2","journal-title":"Mycopathologia"},{"key":"24032_CR48","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1128\/AAC.00390-17","volume":"61","author":"T Gebremariam","year":"2017","unstructured":"Gebremariam T, Alkhazraji S, Lin L, Wiederhold NP, Garvey EP, Hoekstra WJ, Schotzinger RJ, Patterson TF, Filler SG, Ibrahim AS (2017) Prophylactic treatment with VT-1161 protects immunosuppressed mice from Rhizopus arrhizus var. arrhizus infection. Antimicrob Agents Chemother 61:390\u2013417. https:\/\/doi.org\/10.1128\/AAC.00390-17","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR49","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1126\/sciadv.aaw1327","volume":"5","author":"T Gebremariam","year":"2019","unstructured":"Gebremariam T, Alkhazraji S, Soliman SS, Gu Y, Jeon HH, Zhang L, French SW, Stevens DA, Edwards JE, Filler SG, Uppuluri P (2019) Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis. Sci Adv 5:1327. https:\/\/doi.org\/10.1126\/sciadv.aaw1327","journal-title":"Sci Adv"},{"key":"24032_CR50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1172\/JCI71349","volume":"124","author":"T Gebremariam","year":"2014","unstructured":"Gebremariam T, Liu M, Luo G, Bruno V, Phan QT, Waring AJ, Edwards JE, Filler SG, Yeaman MR, Ibrahim AS (2014) CotH3 mediates fungal invasion of host cells during mucormycosis. J Clin Investig 124:237\u2013350. https:\/\/doi.org\/10.1172\/JCI71349","journal-title":"J Clin Investig"},{"key":"24032_CR51","doi-asserted-by":"publisher","first-page":"7815","DOI":"10.1128\/AAC.01437-15","volume":"59","author":"T Gebremariam","year":"2015","unstructured":"Gebremariam T, Wiederhold NP, Fothergill AW, Garvey EP, Hoekstra WJ, Schotzinger RJ, Patterson TF, Filler SG, Ibrahim AS (2015) VT-1161 protects immunosuppressed mice from Rhizopus arrhizus var. arrhizus infection. Antimicrob Agents Chemother 59:7815\u20137817. https:\/\/doi.org\/10.1128\/AAC.01437-15","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR52","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1080\/10428190310001653691","volume":"45","author":"B Gleissner","year":"2004","unstructured":"Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E (2004) Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma 45:1351\u20131360. https:\/\/doi.org\/10.1080\/10428190310001653691","journal-title":"Leuk Lymphoma"},{"key":"24032_CR53","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/s0891-5520(02)00037-5","volume":"16","author":"CE Gonzalez","year":"2002","unstructured":"Gonzalez CE, Rinaldi MG, Sugar AM (2002) Zygomycosis Infect Dis Clin 16:895\u2013914. https:\/\/doi.org\/10.1016\/s0891-5520(02)00037-5","journal-title":"Zygomycosis Infect Dis Clin"},{"key":"24032_CR54","doi-asserted-by":"publisher","first-page":"0179136","DOI":"10.1371\/journal.pone.0179136","volume":"12","author":"J Guinea","year":"2017","unstructured":"Guinea J, Escribano P, Vena A, Mu\u00f1oz P, Mart\u00ednez-Jim\u00e9nez MD, Padilla B, Bouza E (2017) Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: epidemiology and microbiological characterization of the isolates. PLoS One 12:0179136. https:\/\/doi.org\/10.1371\/journal.pone.0179136","journal-title":"PLoS One"},{"key":"24032_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/njms.njms_415_21","volume":"12","author":"A Gupta","year":"2021","unstructured":"Gupta A, Singh V (2021) Mucormycosis: \u201cThe Black Fungus\u201d trampling post-COVID-19 patients. Natl J Maxillofac Surg 12:131. https:\/\/doi.org\/10.4103\/njms.njms_415_21","journal-title":"Natl J Maxillofac Surg"},{"key":"24032_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10787-020-00773-9","volume":"29","author":"A Hariharan","year":"2021","unstructured":"Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M (2021) The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients. Inflammopharmacol 29:91\u2013100. https:\/\/doi.org\/10.1007\/s10787-020-00773-9","journal-title":"Inflammopharmacol"},{"key":"24032_CR57","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1016\/j.ajem.2020.05.114","volume":"38","author":"A Heaney","year":"2020","unstructured":"Heaney A, Griffin G, Simon E (2020) Newly diagnosed diabetes and diabetic ketoacidosis precipitated by COVID-19 infection. Am J Emerg Med 38:2491. https:\/\/doi.org\/10.1016\/j.ajem.2020.05.114","journal-title":"Am J Emerg Med"},{"key":"24032_CR58","unstructured":"Hiroharu C (2021) Mucormycosis treatment agent. JP2021134176"},{"key":"24032_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mmcr.2020.05.008","volume":"29","author":"K Hoang","year":"2020","unstructured":"Hoang K, Abdo T, Reinersman J, Lu R, Higuita N (2020) A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patient. Med Mycol Case Rep 29:22\u201324. https:\/\/doi.org\/10.1016\/j.mmcr.2020.05.008","journal-title":"Med Mycol Case Rep"},{"key":"24032_CR60","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/imm.12394","volume":"144","author":"K Hodgson","year":"2015","unstructured":"Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N (2015) Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology 144:171\u2013185. https:\/\/doi.org\/10.1111\/imm.12394","journal-title":"Immunology"},{"key":"24032_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1439-0507.2006.01295.x","volume":"49","author":"H Hof","year":"2006","unstructured":"Hof H (2006) A new, broad-spectrum azole antifungal: posaconazole-mechanisms of action and resistance, spectrum of activity. Mycoses 49:2\u20136. https:\/\/doi.org\/10.1111\/j.1439-0507.2006.01295.x","journal-title":"Mycoses"},{"key":"24032_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-020-00146-3","volume":"40","author":"S Hojyo","year":"2020","unstructured":"Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, Hirano T (2020) How COVID-19 induces cytokine storm with high mortality. Inflamm Regen 40:1\u20137. https:\/\/doi.org\/10.1186\/s41232-020-00146-3","journal-title":"Inflamm Regen"},{"key":"24032_CR63","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","volume":"69","author":"SG Honavar","year":"2021","unstructured":"Honavar SG (2021) Code mucor: guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol 69:1361\u20131365. https:\/\/doi.org\/10.4103\/ijo.IJO_1165_21","journal-title":"Indian J Ophthalmol"},{"key":"24032_CR64","unstructured":"Hussain A, Tyagi G, Sharma A (2022) A systematic model to detect black fungus appeared during Covid -19 using 3D convolutional neural networks. IN202211042624"},{"key":"24032_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/myc.12232","volume":"3","author":"AS Ibrahim","year":"2014","unstructured":"Ibrahim AS (2014) Host-iron assimilation: pathogenesis and novel therapies of mucormycosis. Mycoses 3:13\u201317. https:\/\/doi.org\/10.1111\/myc.12232","journal-title":"Mycoses"},{"key":"24032_CR66","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1172\/Jci32338","volume":"117","author":"AS Ibrahim","year":"2007","unstructured":"Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW, Schwartz J, Skory CD, Edwards JE, Spellberg BJ (2007) The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Investig 117:2649\u20132657. https:\/\/doi.org\/10.1172\/Jci32338","journal-title":"J Clin Investig"},{"key":"24032_CR67","unstructured":"Ibrahim AS, Liu M, Ghebremariam T, Fu Y, Edwards JE, Filler S (2019a) Immunotherapy and diagnosis of mucormycosis using coth. US2019a0194301"},{"key":"24032_CR68","unstructured":"Ibrahim AS, Soliman S, Edwards J (2019b) Fungal toxins and methods related to the same. US2019b0265238"},{"key":"24032_CR69","unstructured":"Ibrahim AS, Soliman S, Edwards J (2021) Novel fungal toxins and methods related to the same. US20210179695"},{"key":"24032_CR70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/cid\/cir865","volume":"54","author":"AS Ibrahim","year":"2012","unstructured":"Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP (2012) Pathogenesis of mucormycosis. Clin Infect Dis 54:16\u201322. https:\/\/doi.org\/10.1093\/cid\/cir865","journal-title":"Clin Infect Dis"},{"key":"24032_CR71","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","volume":"25","author":"W Jeong","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DC, Chen SA (2019) The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect 25:26\u201334. https:\/\/doi.org\/10.1016\/j.cmi.2018.07.011","journal-title":"Clin Microbiol Infect"},{"key":"24032_CR72","doi-asserted-by":"publisher","first-page":"00487","DOI":"10.1128\/AAC.00487-18","volume":"62","author":"KM J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen KM, Astvad KM, Hare RK, Arendrup MC (2018) EUCAST determination of olorofim (F901318) susceptibility of mold species, method validation, and MICs. Antimicrob Agents Chemother 62:00487. https:\/\/doi.org\/10.1128\/AAC.00487-18","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR73","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/myc.12798","volume":"61","author":"H Kaur","year":"2018","unstructured":"Kaur H, Ghosh A, Rudramurthy SM, Chakrabarti A (2018) Gastrointestinal mucormycosis in apparently immunocompetent hosts-a review. Mycoses 61:898\u2013908. https:\/\/doi.org\/10.1111\/myc.12798","journal-title":"Mycoses"},{"key":"24032_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/molecules26010039","volume":"26","author":"M Khan","year":"2021","unstructured":"Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan ST (2021) COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules 26:39. https:\/\/doi.org\/10.3390\/molecules26010039","journal-title":"Molecules"},{"key":"24032_CR75","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/512817","volume":"44","author":"DP Kontoyiannis","year":"2007","unstructured":"Kontoyiannis DP (2007) Decrease in the number of reported cases of mucormycosis among patients with diabetes mellitus: a hypothesis. Clin Infect Dis 44:1089\u20131090. https:\/\/doi.org\/10.1086\/512817","journal-title":"Clin Infect Dis"},{"key":"24032_CR76","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/428780","volume":"191","author":"DP Kontoyiannis","year":"2005","unstructured":"Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191:1350\u20131360. https:\/\/doi.org\/10.1086\/428780","journal-title":"J Infect Dis"},{"key":"24032_CR77","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50:1091\u20131100. https:\/\/doi.org\/10.1086\/651263","journal-title":"Clin Infect Dis"},{"key":"24032_CR78","unstructured":"Koo S, Marty FM (2019) Volatile metabolite profiles for the diagnosis and treatment of mucorales fungi. US20190183887"},{"key":"24032_CR79","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1073\/pnas.1312789111","volume":"111","author":"PR Kumaresan","year":"2014","unstructured":"Kumaresan PR, Manuri PR, Albert ND, Maiti S, Singh H, Mi T, Roszik J, Rabinovich B, Olivares S, Krishnamurthy J, Zhang L (2014) Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection. Proc Natl Acad Sci 111:10660\u201310665. https:\/\/doi.org\/10.1073\/pnas.1312789111","journal-title":"Proc Natl Acad Sci"},{"key":"24032_CR80","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1046\/j.1440-1827.2003.01548.x","volume":"53","author":"H Kume","year":"2003","unstructured":"Kume H, Yamazaki T, Abe M, Tanuma H, Okudaira M, Okayasu I (2003) Increase in aspergillosis and severe mycotic infection in patients with leukemia and MDS: comparison of the data from the Annual of the Pathological Autopsy Cases in Japan in 1989, 1993 and 1997. Pathol Int 53:744\u2013750. https:\/\/doi.org\/10.1046\/j.1440-1827.2003.01548.x","journal-title":"Pathol Int"},{"key":"24032_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119201","volume":"16","author":"AB Kunnumakkara","year":"2021","unstructured":"Kunnumakkara AB, Rana V, Parama D, Banik K, Girisa S, Sahu H, Thakur KK, Dutta U, Garodia P, Gupta SC, Aggarwal BB (2021) COVID-19, cytokines, inflammation, and spices: how are they related? Life Sci 16:119201. https:\/\/doi.org\/10.1016\/j.lfs.2021.119201","journal-title":"Life Sci"},{"key":"24032_CR82","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cyto.2003.12.010","volume":"26","author":"S Kuvibidila","year":"2004","unstructured":"Kuvibidila S, Warrier RP (2004) Differential effects of iron deficiency and underfeeding on serum levels of interleukin-10, interleukin-12p40, and interferon-gamma in mice. Cytokine 26:73\u201381. https:\/\/doi.org\/10.1016\/j.cyto.2003.12.010","journal-title":"Cytokine"},{"key":"24032_CR83","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/cid\/cir864","volume":"54","author":"KJ Kwon-Chung","year":"2012","unstructured":"Kwon-Chung KJ (2012) Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis 54:8\u201315. https:\/\/doi.org\/10.1093\/cid\/cir864","journal-title":"Clin Infect Dis"},{"key":"24032_CR84","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1128\/AAC.00234-15","volume":"59","author":"F Lamoth","year":"2015","unstructured":"Lamoth F, Alexander BD (2015) Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates. Antimicrob Agents Chemother 59:4308\u20134311. https:\/\/doi.org\/10.1128\/AAC.00234-15","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR85","doi-asserted-by":"publisher","first-page":"01244","DOI":"10.1128\/AAC.01244-19","volume":"63","author":"F Lamoth","year":"2019","unstructured":"Lamoth F, Kontoyiannis DP (2019) Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients. Antimicrob Agents Chemother 63:01244. https:\/\/doi.org\/10.1128\/AAC.01244-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"35","key":"24032_CR86","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cid\/cir880","volume":"54","author":"F Lanternier","year":"2012","unstructured":"Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O, French Mycosis Study Group (2012) A global analysis of mucormycosis in France: the RetroZygo Study (2005\u20132007). Clin Infect Dis 54(35):43. https:\/\/doi.org\/10.1093\/cid\/cir880","journal-title":"Clin Infect Dis"},{"key":"24032_CR87","doi-asserted-by":"publisher","unstructured":"Lelievre L, Garcia-Hermoso D, Abdoul H, Hivelin M, Chouaki T, Toubas D, Mamez AC, Lantieri L, Lortholary O, Lanternier F, and the French Mycosis Study Group (2014) Posttraumatic mucormycosis: a nationwide study in France and review of the literature. Medicine (Baltimore) 93: 395\u2013404. https:\/\/doi.org\/10.1097\/MD.0000000000000221","DOI":"10.1097\/MD.0000000000000221"},{"key":"24032_CR88","unstructured":"Liu L (2021) Antifungal macrocyclic polyene novel compound. CN112175029"},{"key":"24032_CR89","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1172\/JCI42164","volume":"120","author":"M Liu","year":"2010","unstructured":"Liu M, Spellberg B, Phan QT, Fu Y, Fu Y, Lee AS, Edwards JE, Filler SG, Ibrahim AS (2010) The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Investig 120:1914\u20131924. https:\/\/doi.org\/10.1172\/JCI42164","journal-title":"J Clin Investig"},{"key":"24032_CR90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s100670070052","volume":"19","author":"MF Liu","year":"2000","unstructured":"Liu MF, Chen FF, Hsiue TR, Liu CC (2000) Disseminated mucormycosis simulating cerebrovascular disease and pulmonary alveolar haemorrhage in a patient with systemic lupus erythematosus. Clin Rheumatol 19:311\u2013314. https:\/\/doi.org\/10.1007\/s100670070052","journal-title":"Clin Rheumatol"},{"key":"24032_CR91","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3767\/003158513X665539","volume":"30","author":"XL Lu","year":"2013","unstructured":"Lu XL, Najafzadeh MJ, Dolatabadi S, Ran YP, van den Ende AG, Shen YN, Li CY, Xi LY, Hao F, Zhang QQ, Li RY (2013) Taxonomy and epidemiology of Mucor irregularis, agent of chronic cutaneous mucormycosis. Persoonia 30:48. https:\/\/doi.org\/10.3767\/003158513X665539","journal-title":"Persoonia"},{"key":"24032_CR92","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/925135","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4+ T cells: differentiation and functions. Clin Dev Immunol. https:\/\/doi.org\/10.1155\/2012\/925135","journal-title":"Clin Dev Immunol"},{"key":"24032_CR93","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/sj.bmt.1701885","volume":"24","author":"J Maertens","year":"1999","unstructured":"Maertens J, Demuynck H, Verbeken EK, Zachee P, Verhoef GE, Vandenberghe P, Boogaerts MA (1999) Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 24:307\u2013312. https:\/\/doi.org\/10.1038\/sj.bmt.1701885","journal-title":"Bone Marrow Transplant"},{"key":"24032_CR94","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13337-020-00598-8","volume":"31","author":"VK Maurya","year":"2020","unstructured":"Maurya VK, Kumar S, Prasad AK, Bhatt ML, Saxena SK (2020) Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virus Disease 31:179\u2013193. https:\/\/doi.org\/10.1007\/s13337-020-00598-8","journal-title":"Virus Disease"},{"key":"24032_CR95","doi-asserted-by":"publisher","unstructured":"Mehta S, Pandey A (2020a) Rhino-orbital mucormycosis associated with COVID-19. Cureus 12. https:\/\/doi.org\/10.7759\/cureus.10726","DOI":"10.7759\/cureus.10726"},{"key":"24032_CR96","doi-asserted-by":"publisher","first-page":"10726","DOI":"10.7759\/cureus.10726","volume":"12","author":"S Mehta","year":"2020","unstructured":"Mehta S, Pandey A (2020b) Rhino-Orbital mucormycosis associated with COVID-19. Cureus 12:10726. https:\/\/doi.org\/10.7759\/cureus.10726","journal-title":"Cureus"},{"issue":"10","key":"24032_CR97","doi-asserted-by":"publisher","first-page":"8301","DOI":"10.1007\/s11033-020-05831-7","volume":"47","author":"S Meini","year":"2020","unstructured":"Meini S, Giani T, Tascini C (2020) Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2. Mol Biol Rep 47(10):8301\u20138304. https:\/\/doi.org\/10.1007\/s11033-020-05831-7","journal-title":"Mol Biol Rep"},{"key":"24032_CR98","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1128\/AAC.00291-11","volume":"55","author":"M Miyazaki","year":"2011","unstructured":"Miyazaki M, Horii T, Hata K, Watanabe NA, Nakamoto K, Tanaka K, Shirotori S, Murai N, Inoue S, Matsukura M, Abe S (2011) In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds. Antimicrob Agents Chemother 55:4652\u20134658. https:\/\/doi.org\/10.1128\/AAC.00291-11","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR99","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jinf.2016.06.013","volume":"73","author":"J Moreira","year":"2016","unstructured":"Moreira J, Varon A, Galhardo MC, Santos F, Lyra M, Castro R, Oliveira R, Lamas CC (2016) The burden of mucormycosis in HIV-infected patients: a systematic review. J Infect 73:181\u2013188. https:\/\/doi.org\/10.1016\/j.jinf.2016.06.013","journal-title":"J Infect"},{"key":"24032_CR100","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11046-021-00584-8","volume":"186","author":"V Muthu","year":"2021","unstructured":"Muthu V, Rudramurthy SM, Chakrabarti A, Agarwal R (2021) Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world. Mycopathologia 186:739\u2013754. https:\/\/doi.org\/10.1007\/s11046-021-00584-8","journal-title":"Mycopathologia"},{"key":"24032_CR101","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/595846","volume":"48","author":"D Neofytos","year":"2009","unstructured":"Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48:265\u2013273. https:\/\/doi.org\/10.1086\/595846","journal-title":"Clin Infect Dis"},{"key":"24032_CR102","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4314\/eamj.v79i7.8845","volume":"79","author":"JF Onyango","year":"2002","unstructured":"Onyango JF, Kayima JK, Owen WO (2002) Rhinocerebral mucormycosis: case report. East Afr Med J 79:390\u2013393. https:\/\/doi.org\/10.4314\/eamj.v79i7.8845","journal-title":"East Afr Med J"},{"key":"24032_CR103","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1086\/522189","volume":"45","author":"L Pagano","year":"2007","unstructured":"Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, Aloisi T, Irrera G, Bonini A, Picardi M, Caramatti C (2007) Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 45:1161\u20131170. https:\/\/doi.org\/10.1086\/522189","journal-title":"Clin Infect Dis"},{"key":"24032_CR104","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/17474086.2020.1796624","volume":"13","author":"L Pagano","year":"2020","unstructured":"Pagano L, Dragonetti G, De Carolis E, Veltri G, Del Principe MI, Busca A (2020) Developments in identifying and managing mucormycosis in hematologic cancer patients. Expert Rev Hematol 13:895\u2013905. https:\/\/doi.org\/10.1080\/17474086.2020.1796624","journal-title":"Expert Rev Hematol"},{"key":"24032_CR105","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3324\/%25x","volume":"89","author":"L Pagano","year":"2004","unstructured":"Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Picardi M, Corvatta L, D\u2019Antonio D, Girmenia C, Martino P, Del Favero A (2004) Mucormycosis in hematologic patients. Haematologica 89:207\u2013214. https:\/\/doi.org\/10.3324\/%25x","journal-title":"Haematologica"},{"key":"24032_CR106","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3201\/eid1710.110087","volume":"17","author":"BJ Park","year":"2011","unstructured":"Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S (2011) Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001\u20132006. Emerg Infect Dis 17:1855. https:\/\/doi.org\/10.3201\/eid1710.110087","journal-title":"Emerg Infect Dis"},{"key":"24032_CR107","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3201\/eid2709.210934","volume":"27","author":"A Patel","year":"2021","unstructured":"Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, Savio J, Sethuraman N, Madan S, Shastri P, Thangaraju, (2021) Multicenter epidemiologic study of coronavirus disease\u2013associated mucormycosis. India Emerg Infect Dis 27:2349. https:\/\/doi.org\/10.3201\/eid2709.210934","journal-title":"India Emerg Infect Dis"},{"key":"24032_CR108","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/cid\/cir866","volume":"54","author":"G Petrikkos","year":"2012","unstructured":"Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis D (2012) Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54:23\u201334. https:\/\/doi.org\/10.1093\/cid\/cir866","journal-title":"Clin Infect Dis"},{"key":"24032_CR109","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10096-003-1035-y","volume":"22","author":"G Petrikkos","year":"2003","unstructured":"Petrikkos G, Skiada A, Sambatakou H, Toskas A, Vaiopoulos G, Giannopoulou M, Katsilambros N (2003) Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 22:753\u2013756. https:\/\/doi.org\/10.1007\/s10096-003-1035-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"24032_CR110","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1470-9465.2004.00843.x","volume":"10","author":"RM Prabhu","year":"2004","unstructured":"Prabhu RM, Patel R (2004) Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 10:31\u201347. https:\/\/doi.org\/10.1111\/j.1470-9465.2004.00843.x","journal-title":"Clin Microbiol Infect"},{"key":"24032_CR111","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jof5010026","volume":"5","author":"H Prakash","year":"2019","unstructured":"Prakash H, Chakrabarti A (2019) Global Epidemiology Mucormycosis J Fungi 5:26. https:\/\/doi.org\/10.3390\/jof5010026","journal-title":"Global Epidemiology Mucormycosis J Fungi"},{"key":"24032_CR112","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/mmy\/myw014","volume":"54","author":"H Prakash","year":"2016","unstructured":"Prakash H, Ghosh AK, Rudramurthy SM, Paul RA, Gupta S, Negi V, Chakrabarti A (2016) The environmental source of emerging Apophysomyces variabilis infection in India. Sabouraudia 54:567\u2013575. https:\/\/doi.org\/10.1093\/mmy\/myw014","journal-title":"Sabouraudia"},{"key":"24032_CR113","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/mmy\/myy060","volume":"57","author":"H Prakash","year":"2019","unstructured":"Prakash H, Ghosh AK, Rudramurthy SM, Singh P, Xess I, Savio J, Pamidimukkala U, Jillwin J, Varma S, Das A, Panda NK (2019) A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol 57:395\u2013402. https:\/\/doi.org\/10.1093\/mmy\/myy060","journal-title":"Med Mycol"},{"key":"24032_CR114","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/cid\/cir867","volume":"54","author":"B Rammaert","year":"2012","unstructured":"Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O (2012) Healthcare-associated mucormycosis. Clin Infect Dis 54:44\u201354. https:\/\/doi.org\/10.1093\/cid\/cir867","journal-title":"Clin Infect Dis"},{"key":"24032_CR115","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1128\/CMR.13.2.236","volume":"13","author":"JA Ribes","year":"2000","unstructured":"Ribes JA, Vanover-Sams CL, Baker DJ (2000) Zygomycetes in human disease. Clin Microbiol Rev 13:236\u2013301. https:\/\/doi.org\/10.1128\/CMR.13.2.236","journal-title":"Clin Microbiol Rev"},{"key":"24032_CR116","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/jac\/dkz022","volume":"74","author":"O Rivero-Menendez","year":"2019","unstructured":"Rivero-Menendez O, Cuenca-Estrella M, Alastruey-Izquierdo A (2019) In vitro activity of APX001Aagainst rare moulds using EUCAST and CLSI methodologies. J Antimicrob Chemother 74:1295\u20131299. https:\/\/doi.org\/10.1093\/jac\/dkz022","journal-title":"J Antimicrob Chemother"},{"issue":"14","key":"24032_CR117","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3390\/cells11142126","volume":"11","author":"L Rocamora-Reverte","year":"2022","unstructured":"Rocamora-Reverte L, Villunger A, Wiegers GJ (2022) Cell-specific immune regulation by glucocorticoids in murine models of infection and inflammation. Cells 11(14):2126. https:\/\/doi.org\/10.3390\/cells11142126","journal-title":"Cells"},{"key":"24032_CR118","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"MM Roden","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP (2005) Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41:634\u2013653. https:\/\/doi.org\/10.1086\/432579","journal-title":"Clin Infect Dis"},{"key":"24032_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13760-021-01840-w","volume":"24","author":"PK Rudrabhatla","year":"2021","unstructured":"Rudrabhatla PK, Reghukumar A, Thomas SV (2021) Mucormycosis in COVID-19 patients: predisposing factors, prevention and management. Acta Neurol Belg 24:1\u20138. https:\/\/doi.org\/10.1007\/s13760-021-01840-w","journal-title":"Acta Neurol Belg"},{"key":"24032_CR120","unstructured":"Rudrapal M, Celik I, Chinnam S (2022) Inhibitory potential of resveratrol and its natural analogues against RNA dependant RNA polymerase (RDRP) of rhizopus oryzae in mucormycosis through in silico investigations. IN202221008681"},{"key":"24032_CR121","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/jof5010023","volume":"5","author":"A Serris","year":"2019","unstructured":"Serris A, Danion F, Lanternier F (2019) Disease Entities in Mucormycosis. J Fungi 5:23. https:\/\/doi.org\/10.3390\/jof5010023","journal-title":"J Fungi"},{"key":"24032_CR122","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.mycmed.2018.05.008","volume":"28","author":"A Sharifpour","year":"2018","unstructured":"Sharifpour A, Gholinejad-Ghadi N, Ghasemian R, Seifi Z, Aghili SR, Zaboli E, Abdi R, Shokohi T (2018) Voriconazole associated mucormycosis in a patient with relapsed acute lymphoblastic leukemia and hematopoietic stem cell transplant failure: a case report. J Mycol Med 28:527\u2013530. https:\/\/doi.org\/10.1016\/j.mycmed.2018.05.008","journal-title":"J Mycol Med"},{"key":"24032_CR123","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1017\/S0022215121000992","volume":"135","author":"S Sharma","year":"2021","unstructured":"Sharma S, Grover M, Bhargava S, Samdani S, Kataria T (2021) Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol 135:442\u2013447. https:\/\/doi.org\/10.1017\/S0022215121000992","journal-title":"J Laryngol Otol"},{"key":"24032_CR124","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/21505594.2015.1009732","volume":"6","author":"F Shirazi","year":"2015","unstructured":"Shirazi F, Kontoyiannis D, Ibrahim A (2015) Iron starvation induces apoptosis in rhizopus oryzae in vitro. Virulence 6:121\u2013126. https:\/\/doi.org\/10.1080\/21505594.2015.1009732","journal-title":"Virulence"},{"key":"24032_CR125","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5897\/JDE2017.0110","volume":"8","author":"MM Shodja","year":"2017","unstructured":"Shodja MM, Knutsen R, Cao J, Oda K, Beeson LE, Fraser GE, Knutsen S (2017) Effects of glycosylated hemoglobin levels on neutrophilic phagocytic functions. Jacobs J Diabetes Endocrinol 8:9. https:\/\/doi.org\/10.5897\/JDE2017.0110","journal-title":"Jacobs J Diabetes Endocrinol"},{"key":"24032_CR126","doi-asserted-by":"publisher","first-page":"5302","DOI":"10.1128\/IAI.00661-06","volume":"74","author":"AA Siddiqui","year":"2006","unstructured":"Siddiqui AA, Shattock RJ, Harrison TS (2006) Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells. Infect Immun 74:5302\u20135310. https:\/\/doi.org\/10.1128\/IAI.00661-06","journal-title":"Infect Immun"},{"key":"24032_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","volume":"15","author":"AK Singh","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A (2021a) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 15:102146. https:\/\/doi.org\/10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"24032_CR128","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1086\/605445","volume":"200","author":"N Singh","year":"2009","unstructured":"Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Mu\u00f1oz P, Patel R, Fortun J (2009) Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis 200:1002\u20131011. https:\/\/doi.org\/10.1086\/605445","journal-title":"J Infect Dis"},{"key":"24032_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40200-021-00730-5","volume":"21","author":"P Singh","year":"2021","unstructured":"Singh P, Arora S, Mittal N, Singh A, Verma R, Sharma S, Agrawal NK, Goyal S (2021b) Diabetes and rhino-orbito-cerebral mucormycosis-a deadly duo. J Diabetes Metab Disord 21:1\u20137. https:\/\/doi.org\/10.1007\/s40200-021-00730-5","journal-title":"J Diabetes Metab Disord"},{"key":"24032_CR130","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1021\/acsinfecdis.1c00371","volume":"7","author":"R Singh","year":"2021","unstructured":"Singh R, Kumari A (2021) Nasal microbiota imbalance as a contributory link in the emergence of COVID-19 associated mucormycosis. ACS Infect Dis 7:2211\u20132213. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00371","journal-title":"ACS Infect Dis"},{"key":"24032_CR131","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/jof4030090","volume":"4","author":"NV Sipsas","year":"2018","unstructured":"Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP (2018) Therapy of Mucormycosis. J Fungi 4:90. https:\/\/doi.org\/10.3390\/jof4030090","journal-title":"J Fungi"},{"key":"24032_CR132","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","volume":"17","author":"A Skiada","year":"2011","unstructured":"Skiada A, Pagano LI, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M (2011) Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 17:1859\u20131867. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03456.x","journal-title":"Clin Microbiol Infect"},{"key":"24032_CR133","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/jac\/dkr375","volume":"67","author":"R Soman","year":"2012","unstructured":"Soman R, Gupta N, Shetty A, Rodrigues C (2012) Deferasirox inmucormycosis: hopefully, not defeated. J Antimicrob Chemother 67:783\u2013784. https:\/\/doi.org\/10.1093\/jac\/dkr375","journal-title":"J Antimicrob Chemother"},{"key":"24032_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11046-020-00462-9","volume":"31","author":"G Song","year":"2020","unstructured":"Song G, Liang G, Liu W (2020) Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia 31:1\u20138. https:\/\/doi.org\/10.1007\/s11046-020-00462-9","journal-title":"Mycopathologia"},{"key":"24032_CR135","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1080\/21505594.2017.1364335","volume":"8","author":"B Spellberg","year":"2017","unstructured":"Spellberg B (2017) Mucormycosis Pathogenesis: beyond Rhizopus. Virulence 8:1481\u20131482. https:\/\/doi.org\/10.1080\/21505594.2017.1364335","journal-title":"Virulence"},{"key":"24032_CR136","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","volume":"18","author":"B Spellberg","year":"2005","unstructured":"Spellberg B, Edwards J Jr, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18:556\u2013569. https:\/\/doi.org\/10.1128\/CMR.18.3.556-569.2005","journal-title":"Clin Microbiol Rev"},{"key":"24032_CR137","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11908-010-0129-9","volume":"12","author":"B Spellberg","year":"2010","unstructured":"Spellberg B, Ibrahim AS (2010) Recent advances in the treatment of mucormycosis. Curr Infect Dis Rep 12:423\u2013429. https:\/\/doi.org\/10.1007\/s11908-010-0129-9","journal-title":"Curr Infect Dis Rep"},{"key":"24032_CR138","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/jac\/dkr375","volume":"67","author":"B Spellberg","year":"2012","unstructured":"Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP (2012) The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 67:715\u2013722. https:\/\/doi.org\/10.1093\/jac\/dkr375","journal-title":"J Antimicrob Chemother"},{"key":"24032_CR139","unstructured":"Suganantham SV, Sugunadevi C, Samuvel SG (2022) An innovative portable handheld IOT enabled device for the identification of mucormycosis infected images considering the symptom severity for the focused treatment of patients. IN202241041139"},{"key":"24032_CR140","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1128\/AAC.44.7.2004-2006.2000","volume":"44","author":"AM Sugar","year":"2000","unstructured":"Sugar AM, Liu XP (2000) Combination antifungal therapy in treatment of murine pulmonary mucormycosis: roles of quinolones and azoles. Antimicrob Agents Chemother 44:2004\u20132006. https:\/\/doi.org\/10.1128\/AAC.44.7.2004-2006.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"24032_CR141","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3109\/13693786.2012.755574","volume":"51","author":"Y Suzuki","year":"2013","unstructured":"Suzuki Y, Kume H, Togano T, Kanoh Y, Ohto H (2013) Epidemiology of visceral mycoses in autopsy cases in Japan: the data from 1989 to 2009 in the Annual of Pathological Autopsy Cases in Japan. Med Mycol 51:522\u2013526. https:\/\/doi.org\/10.3109\/13693786.2012.755574","journal-title":"Med Mycol"},{"key":"24032_CR142","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jinf.2021.05.015","volume":"21","author":"L Szarpak","year":"2021","unstructured":"Szarpak L, Chirico F, Pruc M, Szarpak L, Dzieciatkowski T, Rafique Z (2021) Mucormycosis-a serious threat in the COVID-19 pandemic. J Infect 21:257. https:\/\/doi.org\/10.1016\/j.jinf.2021.05.015","journal-title":"J Infect"},{"key":"24032_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-021-06862-4","volume":"28","author":"T Tabassum","year":"2021","unstructured":"Tabassum T, Araf Y, Moin AT, Rahaman TI, Hosen MJ (2021) COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression. Mol Biol Rep 28:1\u20138. https:\/\/doi.org\/10.1007\/s11033-021-06862-4","journal-title":"Mol Biol Rep"},{"key":"24032_CR144","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1067\/mhn.2002.126587","volume":"127","author":"YP Talmi","year":"2002","unstructured":"Talmi YP, Goldschmied-Reouven A, Bakon M, Barshack I, Wolf M, Horowitz Z, Berkowicz M, Keller N, Kronenberg J (2002) Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg 127:22\u201331. https:\/\/doi.org\/10.1067\/mhn.2002.126587","journal-title":"Otolaryngol Head Neck Surg"},{"key":"24032_CR145","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1439-0507.1998.tb00609.x","volume":"41","author":"HJ Tietz","year":"1998","unstructured":"Tietz HJ, Brehmer D, J\u00e4nisch W, Martin H, Vorkommen von Endomykosen im Obduktionsgut der Berliner Charit\u00e9 (1998) Incidence of endomycoses in the autopsy material of the Berlin Charit\u00e9 hospital. Mycoses 41:81\u201385. https:\/\/doi.org\/10.1111\/j.1439-0507.1998.tb00609.x","journal-title":"Mycoses"},{"key":"24032_CR146","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3324\/haematol.2016.152900","volume":"102","author":"F Tissot","year":"2017","unstructured":"Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, Lass-Fl\u00f6rl C, Calandra T, Viscoli C, Herbrecht R (2017) ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica 102:433. https:\/\/doi.org\/10.3324\/haematol.2016.152900","journal-title":"Haematologica"},{"key":"24032_CR147","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1440-1827.2005.01817.x","volume":"55","author":"T Tomita","year":"2005","unstructured":"Tomita T, Ho H, Allen M, Diaz J (2005) Mucormycosis involving lungs, heart and brain, superimposed on pulmonary edema. Pathol Int 55:202\u2013205. https:\/\/doi.org\/10.1111\/j.1440-1827.2005.01817.x","journal-title":"Pathol Int"},{"issue":"2051","key":"24032_CR148","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1128\/JCM.02473-06","volume":"45","author":"M Torres-Narbona","year":"2007","unstructured":"Torres-Narbona M, Guinea J, Mart\u00ednez-Alarc\u00f3n J, Mu\u00f1oz P, Gadea I, Emilio Bouza as a representative of the MYCOMED Zygomycosis Study Group (2007) Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol 45(2051):2053. https:\/\/doi.org\/10.1128\/JCM.02473-06","journal-title":"J Clin Microbiol"},{"key":"24032_CR149","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.medmal.2012.10.001","volume":"42","author":"A Toumi","year":"2012","unstructured":"Toumi A, Ammari FL, Loussaief C, Hadhri R, Brahim HB, Harrathi K, Romdhane FB, Koubaa J, Chakroun M (2012) Rhino-orbito-cerebral mucormycosis: five cases. Med Mal Infect 42:591\u2013598. https:\/\/doi.org\/10.1016\/j.medmal.2012.10.001","journal-title":"Med Mal Infect"},{"key":"24032_CR150","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bmt.1705614","volume":"39","author":"SM Trifilio","year":"2007","unstructured":"Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, Chamilos G, Palella F, Kennedy L, Mullane K, Tallman MS (2007) Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 39:425\u2013429. https:\/\/doi.org\/10.1038\/sj.bmt.1705614","journal-title":"Bone Marrow Transplant"},{"key":"24032_CR151","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/postgradmedj-2020-138234","volume":"96","author":"S Umakanthan","year":"2020","unstructured":"Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF, Dahal S, Kumar H, Dhananjaya KV (2020) Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J 96:753\u2013758. https:\/\/doi.org\/10.1136\/postgradmedj-2020-138234","journal-title":"Postgrad Med J"},{"key":"24032_CR152","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/mmy\/myz012","volume":"57","author":"R Van Daele","year":"2019","unstructured":"Van Daele R, Spriet I, Wauters J, Maertens J, Mercier T, Van Hecke S, Br\u00fcggemann R (2019) Antifungal drugs: what brings the future? Med Mycol 57:328\u2013343. https:\/\/doi.org\/10.1093\/mmy\/myz012","journal-title":"Med Mycol"},{"key":"24032_CR153","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/coa.13175","volume":"43","author":"C Vaughan","year":"2018","unstructured":"Vaughan C, Bartolo A, Vallabh N, Leong SC (2018) A meta-analysis of survival factors in rhino-orbital-cerebral mucoromycosis-has anything changed in the past 20 years? Clin Otolaryngol 43:1454\u20131464. https:\/\/doi.org\/10.1111\/coa.13175","journal-title":"Clin Otolaryngol"},{"key":"24032_CR154","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1086\/427752","volume":"40","author":"S Vigouroux","year":"2005","unstructured":"Vigouroux S, Morin O, Moreau P, M\u00e9chinaud F, Morineau N, Mah\u00e9 B, Chevallier P, Guillaume T, Dubruille V, Harousseau JL, Milpied N (2005) Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis 40:35\u201337. https:\/\/doi.org\/10.1086\/427752","journal-title":"Clin Infect Dis"},{"key":"24032_CR155","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11046-014-9752-6","volume":"178","author":"K Vinay","year":"2014","unstructured":"Vinay K, Chandrasegaran A, Kanwar AJ, Saikia UN, Kaur H, Shivaprakash MR, Dogra S (2014) Primary cutaneous mucormycosis presenting as a giant plaque: uncommon presentation of a rare mycosis. Mycopathologia 178:97\u2013101. https:\/\/doi.org\/10.1007\/s11046-014-9752-6","journal-title":"Mycopathologia"},{"key":"24032_CR156","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s11046-019-00403-1","volume":"185","author":"G Walther","year":"2020","unstructured":"Walther G, Wagner L, Kurzai O (2020) Outbreaks of mucorales and the species involved. Mycopathologia 185:765\u2013781. https:\/\/doi.org\/10.1007\/s11046-019-00403-1","journal-title":"Mycopathologia"},{"key":"24032_CR157","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, Mc Googan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (Covid-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 323:1239\u20131242. https:\/\/doi.org\/10.1001\/jama.2020.2648","journal-title":"JAMA"},{"key":"24032_CR158","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1128\/JCM.06611-11","volume":"50","author":"I Xess","year":"2012","unstructured":"Xess I, Mohapatra S, Shivaprakash MR, Chakrabarti A, Benny GL, O\u2019Donnell K, Padhye AA (2012) Evidence implicating Thamnostylum lucknowense as an etiological agent of rhino-orbital mucormycosis. J Clin Microbiol 50:1491\u20131494. https:\/\/doi.org\/10.1128\/JCM.06611-11","journal-title":"J Clin Microbiol"},{"key":"24032_CR159","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1469-0691.2012.03908.x","volume":"18","author":"A Xhaard","year":"2012","unstructured":"Xhaard A, Lanternier F, Porcher R, Dannaoui E, Bergeron A, Clement L, Lacroix C, Herbrecht R, Legrand F, Mohty M, Michallet M (2012) Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003\u20132008). Clin Microbiol Infect 18:396\u2013400. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03908.x","journal-title":"Clin Microbiol Infect"},{"key":"24032_CR160","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1128\/JCM.37.6.1732-1738.1999","volume":"37","author":"T Yamazaki","year":"1999","unstructured":"Yamazaki T, Kume H, Murase S, Yamashita E, Arisawa M (1999) Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microbiol 37:1732\u20131738. https:\/\/doi.org\/10.1128\/JCM.37.6.1732-1738.1999","journal-title":"J Clin Microbiol"},{"key":"24032_CR161","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/diseases9040065","volume":"9","author":"F Yasmin","year":"2021","unstructured":"Yasmin F, Najeeb H, Naeem A, Dapke K, Phadke R, Asghar MS, Shah SM, De Berardis D, Ullah I (2021) COVID-19 associated mucormycosis: a systematic review from diagnostic challenges to management. Diseases 9:65. https:\/\/doi.org\/10.3390\/diseases9040065","journal-title":"Diseases"},{"key":"24032_CR162","unstructured":"Yuanming Y, Tian D, Donghong L, Xingqian Y, Xiaoben X, Yibiao P (2019) Method for Inoculating Fermented Bean Curd Blank. CN110089577"}],"container-title":["Environmental Science and Pollution Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-022-24032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11356-022-24032-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-022-24032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T05:39:13Z","timestamp":1675402753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11356-022-24032-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":161,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["24032"],"URL":"https:\/\/doi.org\/10.1007\/s11356-022-24032-2","relation":{},"ISSN":["1614-7499"],"issn-type":[{"value":"1614-7499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"22 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors have approved the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}